Paper
7 September 2023 Mechanism of COVID-19 rebound post antiviral treatment
Mengtian Huang
Author Affiliations +
Proceedings Volume 12789, International Conference on Modern Medicine and Global Health (ICMMGH 2023); 1278933 (2023) https://doi.org/10.1117/12.2692465
Event: International Conference on Modern Medicine and Global Health (ICMMGH 2023), 2023, Oxford, United Kingdom
Abstract
COVID-19 have caused a great burden in health care and in terms of finance. Despite the current control of COVID-19 in many countries due to the application of vaccination and treatments, the rebound of COVID-19 symptoms or repositive cases examined by either antigen test or reverse transcription-polymerase chain reaction (RT-PCR) have been noticed in patients post recovery, especially after certain treatments. However, if the rebound was a part of natural course of COVID-19 recovery, or if it was triggered by certain factors, have not been confirmed. Herein, we reviewed the history and time course of COVID-19 rebound in patients without treatment. Further, we compared the rebound rate in patients treated with Paxlovid or Molnupiravir, the two recently approved treatments for COVID-19. In addition, the present study summarizes the possible causes and the clinical implication of studying COVID-19 rebound in patients with or without treatments. At present, the existing studies on COVID-19 rebound are not enough. More studies and data are warranted to analyze factors associated with the occurrence of COVID-19 rebound.
© (2023) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Mengtian Huang "Mechanism of COVID-19 rebound post antiviral treatment", Proc. SPIE 12789, International Conference on Modern Medicine and Global Health (ICMMGH 2023), 1278933 (7 September 2023); https://doi.org/10.1117/12.2692465
Advertisement
Advertisement
RIGHTS & PERMISSIONS
Get copyright permission  Get copyright permission on Copyright Marketplace
KEYWORDS
COVID 19

Nucleic acids

Antibodies

Chest

Pulmonary disorders

Diseases and disorders

Lung

RELATED CONTENT


Back to Top